DIABETES AND HEART
The connection between heart diseases and hyperglycemia is one of the most studied health issues. Many medicines are used to reduce hyperglycemia and cardiovascular events and, nowadays, since we can treat both diseases at the same time, it is very important that cardiologists know more about them.
related research activities
27) Aging and migratory dynamics: an epidemiological, socio-cultural and functional evaluation in elderly migrant patients
L. Sutera M. Affronti, G. Fazio, L. J. Dominguez, M. Barbagallo
G Gerontol 2007;55:195-198
29) Deficit dell’ormone della crescita GH (nanismo ipofisario) e aumento del rischio coronario
G Novo, C Visconti, G Ciaramitaro, M Farinella, G Fazio, A Rotolo, I Marturana, M Caruso, E Hoffmann, S Novo P Assennato
Infarto.it 2007
50) L’azitromicina nel trattamento della gastroparesi diabetica nell’anziano: un caso clinico
L. Sutera, G. Fazio, V. Brucato, G. Marchese, L.J. Dominguez, G. Costanza, M. Barbagallo
G Gerontol 2008;56:45-49
53) Growth hormone deficiency and increased coronary risk
Novo G, Visconti C, Ciaramitaro GF, Farinella M, Rotolo A, Fazio G, Marturana I, Caruso M, Hoffmann E, Novo S, Assennato P.
Minerva Cardioangiol. 2008; 56(4):442-4
58) Il rischio cardiovascolare globale nella sindrome metabolica del ambino
F.Ferrara, G.Fazio, F.Cardella, S.Novo
Minerva Cardioangiol. 2008;suppl. al numero 6:50-2.
71) Atherosclerosis, inflammation and Chlamidia Pneumoniae
G Fazio, M Giovino, A Gullotti, D Bacarella, G Novo, S Novo
World J Cardiol 2009; 1, 31-41
91) Obesity: a new pathology to pay attention to in young people.
Fazio G, Vernuccio D, Di Gesaro G, Bacarella D, D’Angelo L, Novo G, Novo S.
Curr Pharm Des. 2010;16(4):463-7. (IF 4,399)
107) Hsp60 and heme oxygenase-1 (Hsp32) in acute myocardial infarction.
Novo G, Cappello F, Rizzo M, Fazio G, Zambuto S, Tortorici E, Marino Gammazza A, Corrao S, Zummo G, De Macario EC, Macario AJ,
Assennato P, Novo S, Li Volti G.
Transl Res. 2011 May;157(5):285-92. (IF 1,222)